Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-25,492
Closed -$3.49M 4638
2017
Q4
$3.49M Buy
25,492
+15,132
+146% +$2M 0.02% 1030
2017
Q3
$1.34M Sell
10,360
-59,247
-85% -$7.9M 0.01% 1701
2017
Q2
$9.22M Buy
69,607
+54,359
+356% +$6.66M 0.05% 414
2017
Q1
$1.88M Sell
15,248
-9,429
-38% -$1.12M 0.02% 1185
2016
Q4
$2.72M Buy
24,677
+12,106
+96% +$1.34M 0.02% 1080
2016
Q3
$1.49M Buy
12,571
+4,423
+54% +$521K 0.01% 1479
2016
Q2
$912K Sell
8,148
-36,433
-82% -$3.92M 0.01% 1875
2016
Q1
$4.49M Sell
44,581
-76,475
-63% -$7.33M 0.04% 674
2015
Q4
$12.9M Buy
121,056
+80,083
+195% +$8.26M 0.09% 287
2015
Q3
$3.82M Buy
40,973
+5,355
+15% +$554K 0.02% 1086
2015
Q2
$3.71M Sell
35,618
-815
-2% -$84.8K 0.02% 1031
2015
Q1
$3.95M Buy
36,433
+34,687
+1,987% +$3.57M 0.03% 812
2014
Q4
$162K Buy
+1,746
New +$154K ﹤0.01% 3526
2014
Q3
Sell
-5,820
Closed -$512K 4935
2014
Q2
$512K Buy
+5,820
New +$504K ﹤0.01% 2295

Other funds holding LH

PEAK6 Group's LH Position: Q4 2017 in Review

PEAK6 Group sold out of Labcorp (LH) in Q4 2017, closing a stake of 17 shares — an estimated $2.25K sold.

PEAK6 Group first reported a position in LH in Q2 2013 and held it in 11 quarters. The position peaked at $2.4M in Q4 2014. 753 funds tracked by Wall St. Rank hold LH as of Q4 2017.

  • PEAK6 Group reported no remaining Labcorp position as of Q4 2017 after selling out during the quarter.
  • PEAK6 Group sold 17 Labcorp shares in Q4 2017, an estimated $2.25K.
  • PEAK6 Group first reported a position in Labcorp in Q2 2013 and held it in 11 quarters.
  • PEAK6 Group's Labcorp position peaked at $2.4M in Q4 2014.
  • 753 funds tracked by Wall St. Rank held Labcorp as of Q4 2017.

Based on PEAK6 Group's 13F filing for Q4 2017, filed 14 Feb 2018.